Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial
--------------------------------------------------------------------
Source: CNBC
Published: 2026-03-19 21:45 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Law & Courts, Drugs, Crime & Justice
--------------------------------------------------------------------
Snippet:
Eli Lilly on Thursday said its next-generation obesity drug retatrutide cleared its first late-stage trial on Type 2 diabetes patients, helping them manage their blood sugar levels and lose weight.
--------------------------------------------------------------------